203 related articles for article (PubMed ID: 19190347)
1. Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
Kwon J; Stephan S; Mukhopadhyay A; Muders MH; Dutta SK; Lau JS; Mukhopadhyay D
Cancer Res; 2009 Feb; 69(4):1350-7. PubMed ID: 19190347
[TBL] [Abstract][Full Text] [Related]
2. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
[TBL] [Abstract][Full Text] [Related]
3. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.
Neid M; Datta K; Stephan S; Khanna I; Pal S; Shaw L; White M; Mukhopadhyay D
J Biol Chem; 2004 Feb; 279(6):3941-8. PubMed ID: 14604996
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
Stoeltzing O; Liu W; Fan F; Wagner C; Stengel K; Somcio RJ; Reinmuth N; Parikh AA; Hicklin DJ; Ellis LM
Cancer Lett; 2007 Dec; 258(2):291-300. PubMed ID: 17950526
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
[TBL] [Abstract][Full Text] [Related]
10. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
11. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
[TBL] [Abstract][Full Text] [Related]
12. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
13. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
[TBL] [Abstract][Full Text] [Related]
16. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
[TBL] [Abstract][Full Text] [Related]
17. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
18. Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line.
Zeng H; Datta K; Neid M; Li J; Parangi S; Mukhopadhyay D
Biochem Biophys Res Commun; 2003 Feb; 302(1):46-55. PubMed ID: 12593846
[TBL] [Abstract][Full Text] [Related]
19. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
